Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06939712

A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Crohn's disease (CD) is a chronic, nonspecific inflammatory disease that can affect the entire digestive tract. It is difficult to cure and often relapses, causing long-term suffering for patients. This persistent condition significantly impacts their mental and psychological well-being, leading to a noticeable decline in their quality of life. Furthermore, these negative emotions can contribute to disease recurrence and the worsening of symptoms. Positive psychological intervention (PPI) refers to the enhancement of positive emotions, cognition, and behaviors to increase well-being and alleviate symptoms. Therefore, this study aims to use psychological methods to help CD patients better recognize and understand their positive experiences, thus aiding them in coping with stress and adversity more effectively.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOnline Positive Psychology InterventionA 6-week online psychological support program, held once a week, primarily organized by a facilitator, with patient-led discussions and communication.
OTHERRoutine CareA 6-week program of health education provided by IBD specialists and nurses during patient follow-ups, tailored to individual patient circumstances and needs. Topics include IBD disease knowledge, medication management, diet, exercise, lifestyle, psychological support, and follow-up care. Patients in this group will also join a control group WeChat group for study-related communication.

Timeline

Start date
2025-05-01
Primary completion
2025-12-31
Completion
2026-04-01
First posted
2025-04-23
Last updated
2025-07-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06939712. Inclusion in this directory is not an endorsement.